By Stanley Langer, RSC Chilterns & Middlesex local section committee
On 10 December 2018, Royal Society of Chemistry blue plaque unveiling ceremonies took place at two sites of the Institute for Cancer Research (ICR) in Chelsea and Sutton.
The RSC was represented by members from the Chilterns & Middlesex and Downland local sections, respectively.
The blue plaques are Chemical Landmark Awards and the ICR’s award marked its role in cancer drug discovery from the 1950s until the present day – including the discovery of the chemotherapy drug carboplatin, the prostate cancer drug abiraterone and the genetic targeting of olaparib for ovarian and breast cancer.
The two ceremonies took place via a skype link between the lecture theatres in Chelsea and Sutton. Paul Workman, the Institute’s CEO, opened proceedings and this was followed by short talks from Beverley Weston and Professor Dominic Tildesley, Past President of the RSC (in Chelsea) and from Chris Williamson, Downland Section (in Sutton), following which the blue plaques were unveiled.
Short talks on the history of drug discovery at the ICR were then given by Paul Workman and Ian Collins (Head of Chemistry in the Cancer Therapeutics Unit) at the respective sites and the event concluded with drinks receptions.
If you've been involved in an event or activity, or just have an interesting story to tell, we want to hear from you! Please get in touch using the online form or tweet us @RoySocChem using #time4chem.